These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 9412209

  • 41. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
    Guibert J, Acar JF, Justin C, Kitzis MD.
    Nouv Presse Med; 1981 Feb 26; 10(8):625-7. PubMed ID: 6259607
    [Abstract] [Full Text] [Related]

  • 42. Clinical evaluation of cefotiam (CGP/14221) versus cephalothin in the treatment of urinary tract infections.
    Tselentis J, Cordossis T, Eliopoulos G.
    Pharmatherapeutica; 1983 Feb 26; 3(6):382-7. PubMed ID: 6312460
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG, Graham MR, Lindsey CC, Lamp KC, Freeman C, Glaros A.
    Am J Geriatr Pharmacother; 2004 Sep 26; 2(3):181-9. PubMed ID: 15561650
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Cost comparison of single daily i.v. doses of ceftriaxone versus continuous infusion of cefotaxime.
    Hitt CM, Nightingale CH, Quintiliani R, Nicolau DP.
    Am J Health Syst Pharm; 1997 Jul 15; 54(14):1614-8. PubMed ID: 9248605
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Ceftriaxone monotherapy for the treatment of febrile neutropenia in patients with solid tumors: a prospective study of 100 episodes.
    Chamorey E, Magne N, Foa C, Otto J, Largillier R, Viot M, Benard-Thiery I, Thyss A.
    Med Sci Monit; 2004 Nov 15; 10(11):PI119-25. PubMed ID: 15507863
    [Abstract] [Full Text] [Related]

  • 52. Clinical and bacteriologic efficacy of ceftriaxone in the United States.
    McCloskey RV.
    Am J Med; 1984 Oct 19; 77(4C):97-103. PubMed ID: 6093528
    [Abstract] [Full Text] [Related]

  • 53. Cefotaxime versus ceftriaxone for the treatment of nosocomial pneumonia. Results of a multicenter study.
    Shah PM, Stille W.
    Diagn Microbiol Infect Dis; 1995 Oct 19; 22(1-2):171-2. PubMed ID: 7587035
    [Abstract] [Full Text] [Related]

  • 54. Single-dose ceftriaxone versus multi-dose cefotaxime as short-term antimicrobial prophylaxis in urologic surgery. Preliminary results of a multicenter prospective randomized study.
    Periti P, Mazzei T, Lamanna S, Mini E.
    Chemioterapia; 1984 Oct 19; 3(5):295-8. PubMed ID: 6099756
    [Abstract] [Full Text] [Related]

  • 55. [Comparative assessment of efficacy of the 3d generation cephalosporins, ceftriabol, and claforan, in patients with community-acquired pneumonia].
    Vakhrushev IaM, Starodubtseva OI.
    Klin Med (Mosk); 2009 Oct 19; 87(7):53-5. PubMed ID: 19705794
    [Abstract] [Full Text] [Related]

  • 56. [Clinical studies of the efficacy and tolerance of cefotaxime, ceftizoxime and ceftriaxone in patients with complicated urinary tract infections].
    Westenfelder M, Pelz K.
    Infection; 1983 Oct 19; 11(6):296-301. PubMed ID: 6321356
    [Abstract] [Full Text] [Related]

  • 57. Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis.
    Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W.
    Clin Infect Dis; 2003 Jun 15; 36(12):1507-13. PubMed ID: 12802748
    [Abstract] [Full Text] [Related]

  • 58. Cefotaxime twice daily versus ceftriaxone once daily. A randomized controlled study in patients with serious infections.
    Simmons BP, Gelfand MS, Grogan J, Craft B.
    Diagn Microbiol Infect Dis; 1995 Jun 15; 22(1-2):155-7. PubMed ID: 7587031
    [Abstract] [Full Text] [Related]

  • 59. [Ceftriaxone (Rocefin) in the treatment of bronchopulmonary infections].
    Nonikov VE, Konstantinova TD, Makarova OV, Manziuk EN, Minaev VI, Ritchik LA.
    Ter Arkh; 1997 Jun 15; 69(10):84-8. PubMed ID: 9471801
    [Abstract] [Full Text] [Related]

  • 60. A single dose of ceftriaxone administered 30 minutes before percutaneous endoscopic gastrostomy significantly reduces local and systemic infective complications.
    Dormann AJ, Wigginghaus B, Risius H, Kleimann F, Kloppenborg A, Grünewald T, Huchzermeyer H.
    Am J Gastroenterol; 1999 Nov 15; 94(11):3220-4. PubMed ID: 10566718
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.